Antihypertensive Drugs Market Share Blank Liverpool Shirt , Trend, Segmentation and Forecast to 2023 by Metcarl · November 22, 2018
Human health is being affected by various factors which include rapid urbanization, demographic ageing and the globalization of unhealthy lifestyles. Hypertension is one of the keyhealth issuesthat are observed in both developed as well as developing countries. It is a silent, invisible killer that rarely causes symptoms and is one of the key risk factors forcoronary heart disease and ischemic as well as hemorrhagic stroke. Hypertension can also lead to various other problemssuch as renal impairment, visual impairment, heart failure and retinal hemorrhage. According to the World Health Organization (WHO), 7.5 million deaths globally are caused due to hypertension Xherdan Shaqiri Shirt , and it accounts to 12.8% of the total deaths. Globally,in 2008 prevalence of hypertension was observed to be around 40% in adults aged 25. According to the National Health and Nutrition Evaluation Survey, ithas been noted that in United States from 2007 to 2010,81.5% of the population is aware of their hypertension condition, out of which 74% are being treated and only 52.5% are under control.
Read Report Overview @
Theantihypertensive drugs market based on the therapy area is classified into diuretics (hydrochlorothiazide and indapamide), calcium channel blockers (nifedipine, felodipine and diltiazem), angiotensin receptor blockers or ARBs (losartan) Kamil Grabara Shirt , angiotensin converting enzyme (ACE)inhibitors (captopril, lisinopril and perindopril), beta blockers vasodilators (atenolol and propranolol), alpha blockers (clonidine, guanabenz), and renin etics being the first line of treatment for hypertension holds the major share of the market. All these drug classes (drugs) have shown to reduce cardiovascular morbidity and mortality. The drugs are administered either as a single or combined dose depending upon the stage of hypertension, whilethe choice of drugs depends upon the patients鈥?medical history and current conditions.
On the basis of the geography, the antihypertensive market can be segmented into North America Rafael Camacho Shirt , Europe, AsiaPacific, Latin America, and Middle East and global antihypertensive market is dominated mainly by North America and Europe. According to the WHO, the prevalence of hypertension is highest in Africa and lowest in Americas. In Africa more than 40% of the adults suffer from hypertension and many of them remain undiagnosed due to the high cost of increased genericization by the local companies can be a challenge for the market. Similarly, in recent years, there has beena significant improvement in the management of hypertension contributing to a strong decline in the death rates in North America and Western Europe
The change in lifestyle, elevated stress level Caoimhin Kelleher Shirt , and rise in prevalent population, early detection and penetration of combined dose would be the main factors to drive the growth of antihypertensive market. The patent expiry for major drugs such as Diovan (Novartis), Cozaar (Merck),Revatio (Pfizer), Exforge (Novartis), Atacand (AstraZeneca), Avapro (Sanofi Aventis), BIopress(Takeda) and Benicar (Daiichi Sankyo) Curtis Jones Shirt , along with low diagnostics rate and increased generic penetration would result in the antihypertensive market slowdown, but the novel antihypertensive drugs in the pipeline can recover the losses of patent expiration.
Obtain the Report Brochure @ ;rep_id=7718
Some of the major key players in the global antihypertensive market includes Novartis AG, Pfizer Inc., Sanofi S.A, Johnson & Johnson Ltd., Daiichi – Sankyo, Merck & Co., AstraZeneca Plc. Nathaniel Phillips Shirt ,Ranbaxy Laboratories Limited and Lupin Limited.
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Global Pre-Filled Syringes Market Worth $7,629m In 2021 Health Articles | November 13, 2017
The global pre-filled syringes market is expected to grow at a moderate growth rate over the forecast period. The global pre-filled syringes market was valued at $4,663m in 2016. Visiongain forecasts this market to increase to $7,629m in 2021. The market will then continue to increase to $12 Alisson Becker Shirt ,764m in 2027, growing at a CAGR of 9.7% between 2016 and 2027.
LONDON, UK March 2017: Visiongain’s new report Global Pre-Filled Syringes Market Forecast 2017-2027: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes, Pen Injectors and Autoinjectors indicates that the global pre-filled syringes market will see $7,629m in spending in 2021.
www.VW-Audi-Treff.de
Thema drucken
22.04.2019 07:56
Antworten
